Correction: Inhalable solid lipid nanoparticles for intracellular tuberculosis infection therapy: macrophage-targeting and pH-sensitive properties.

Ma, Cheng; Wu, Mingjun; Ye, Weifen; Huang, Zhengwei; Ma, Xiangyu; Wang, Wenhao; Wang, Wenhua; Huang, Ying; Pan, Xin; Wu, Chuanbin

Ma, Cheng; Wu, Mingjun; Ye, Weifen; Huang, Zhengwei; Ma, Xiangyu; Wang, Wenhao; Wang, Wenhua; Huang, Ying; Pan, Xin; Wu, Chuanbin.

Afiliación

Ma C; School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, 510006, China.
Wu M; School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, 510006, China.
Ye W; School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, 510006, China.
Huang Z; School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, 510006, China.
Ma X; College of Pharmacy, Molecular Pharmaceutics and Drug Delivery, The University of Texas at Austin, Austin, TX, USA.
Wang W; School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, 510006, China.
Wang W; School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, 510006, China.
Huang Y; School of Pharmacy, Jinan University, Guangzhou, 510632, People's Republic of China. huangy2007@163.com.
Pan X; School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, 510006, China.
Wu C; School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, 510006, China.

Drug Deliv Transl Res ; 12(11): 2893, 2022 Nov.

Article en En | MEDLINE | ID: mdl-35441322

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 3_ND Problema de salud: 3_neglected_diseases / 3_tuberculosis Tipo de estudio: Diagnostic_studies Idioma: En Revista: Drug Deliv Transl Res Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google